title: Evidence and nuances of propranolol safety.
authors: Department of Dermatology, Division of Pediatric Dermatology, Johns Hopkins University School of Medicine, 200 North Wolfe Street, Unit 2107, Baltimore, 21287, MD, U.S.A. kateputtgen@jhmi.edu.
authors: K B
authors: KB
authors: Püttgen
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011433:Propranolol / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011433:Propranolol